224 related articles for article (PubMed ID: 27007263)
21. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
Falzon K; Drimtzias E; Picton S; Simmons I
Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
[TBL] [Abstract][Full Text] [Related]
22. Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.
Henning AM; Handrup MM; Kjeldsen SM; Larsen DA; Ejerskov C
Orphanet J Rare Dis; 2021 Nov; 16(1):489. PubMed ID: 34809690
[TBL] [Abstract][Full Text] [Related]
23. Prechiasmatic transection of the optic nerve in optic nerve glioma: technical description and surgical outcome.
Borghei-Razavi H; Shibao S; Schick U
Neurosurg Rev; 2017 Jan; 40(1):135-141. PubMed ID: 27230830
[TBL] [Abstract][Full Text] [Related]
24. Optic pathway gliomas in children with and without neurofibromatosis 1.
Czyzyk E; Jóźwiak S; Roszkowski M; Schwartz RA
J Child Neurol; 2003 Jul; 18(7):471-8. PubMed ID: 12940652
[TBL] [Abstract][Full Text] [Related]
25. NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat.
Azizi AA; Walker DA; Liu JF; Sehested A; Jaspan T; Pemp B; Simmons I; Ferner R; Grill J; Hargrave D; Driever PH; Evans DG; Opocher E;
Neuro Oncol; 2021 Jan; 23(1):100-111. PubMed ID: 32628746
[TBL] [Abstract][Full Text] [Related]
26. Optic Gliomas in Neurofibromatosis Type 1.
Parkhurst E; Abboy S
J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma.
Cambiaso P; Galassi S; Palmiero M; Mastronuzzi A; Del Bufalo F; Capolino R; Cacchione A; Buonuomo PS; Gonfiantini MV; Bartuli A; Cappa M; Macchiaiolo M
Am J Med Genet A; 2017 Sep; 173(9):2353-2358. PubMed ID: 28631895
[TBL] [Abstract][Full Text] [Related]
28. The role of visual electrodiagnostics in management of children with neurofibromatosis type 1.
Tekavčič Pompe M; Pečarič Meglič N; Šuštar Habjan M
Doc Ophthalmol; 2023 Apr; 146(2):121-136. PubMed ID: 36652041
[TBL] [Abstract][Full Text] [Related]
29. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
Avery RA; Bouffet E; Packer RJ; Reginald A
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1034-8. PubMed ID: 23329671
[TBL] [Abstract][Full Text] [Related]
30. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
Campagna M; Opocher E; Viscardi E; Calderone M; Severino SM; Cermakova I; Perilongo G
Pediatr Blood Cancer; 2010 Dec; 55(6):1083-8. PubMed ID: 20979170
[TBL] [Abstract][Full Text] [Related]
31. Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma.
Boonzaier NR; Hales PW; D'Arco F; Walters BC; Kaur R; Mankad K; Cooper J; Liasis A; Smith V; O'Hare P; Hargrave D; Clark CA
Neuroimage Clin; 2020; 28():102447. PubMed ID: 33038669
[TBL] [Abstract][Full Text] [Related]
32. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
Kelly JP; Leary S; Khanna P; Weiss AH
Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
[TBL] [Abstract][Full Text] [Related]
34. Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary?
Maloney E; Stanescu AL; Perez FA; Iyer RS; Otto RK; Leary S; Steuten L; Phipps AI; Shaw DWW
Pediatr Radiol; 2018 Sep; 48(10):1472-1484. PubMed ID: 29789890
[TBL] [Abstract][Full Text] [Related]
35. Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence.
Moreno L; Bautista F; Ashley S; Duncan C; Zacharoulis S
Eur J Cancer; 2010 Aug; 46(12):2253-9. PubMed ID: 20400294
[TBL] [Abstract][Full Text] [Related]
36. Isolated optic nerve gliomas: a multicenter historical cohort study.
Shofty B; Ben-Sira L; Kesler A; Jallo G; Groves ML; Iyer RR; Lassaletta A; Tabori U; Bouffet E; Thomale UW; Hernáiz Driever P; Constantini S;
J Neurosurg Pediatr; 2017 Dec; 20(6):549-555. PubMed ID: 28984541
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic factors of neurofibromatosis type 1-associated optic pathway gliomas in children].
Florent C; Beylerian M; Mairot K; Dambricourt L; André N; David T; Girard N; Audic F; Denis D
J Fr Ophtalmol; 2022 Feb; 45(2):173-184. PubMed ID: 34972579
[TBL] [Abstract][Full Text] [Related]
38. Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.
Avery RA; Mansoor A; Idrees R; Biggs E; Alsharid MA; Packer RJ; Linguraru MG
Neurology; 2016 Jun; 86(24):2264-70. PubMed ID: 27170570
[TBL] [Abstract][Full Text] [Related]
39. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
Zeid JL; Charrow J; Sandu M; Goldman S; Listernick R
J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1.
Kotch C; Avery R; Getz KD; Bouffet E; de Blank P; Listernick R; Gutmann DH; Bornhorst M; Campen C; Liu GT; Aplenc R; Li Y; Fisher MJ
Neuro Oncol; 2022 Aug; 24(8):1377-1386. PubMed ID: 35018469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
